AgingResearch.News
Arthritis & Rheumatology

Anifrolumab Versus Belimumab for Cardiovascular Disease Risk in Systemic Lupus Erythematosus

By Arjun Mahajan, Maureen Whittelsey, Ruth Ann Vleugels, Show 5 more authorsJeffrey A. Sparks
Study in peopleInterventions
Paper

The paper

Arjun Mahajan, Maureen Whittelsey, Ruth Ann Vleugels, Show 5 more authorsJeffrey A. Sparks

Brigham and Women's Hospital

Arthritis & Rheumatology, 7 Aug 2026

doi.org/10.1002/art.70293PubMed 42565362

More in Interventions